PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL • Market segmentation by distribution channel • Comparison by distribution channel • Direct sales - Market size and forecast 2018-2023 • Retail sales - Market size and forecast 2018-2023 • Market opportunity by distribution channel PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY SERVICE • Market segmentation by service PART 09: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Advances in next-generation genetic sequencing • Reduction in the cost of services • Growing adoption of online service platforms PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • 23andMe Inc. • Invitae Corp. • Laboratory Corp. of America Holdings • Myriad Genetics Inc. • Quest Diagnostics Inc. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Distribution channel - Market share 2018-2023 (%) Exhibit 19: Comparison by distribution channel Exhibit 20: Direct sales - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Direct sales - Year-over-year growth 2019-2023 (%) Exhibit 22: Retail sales - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Retail sales - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by distribution channel Exhibit 25: Customer landscape Exhibit 26: Global direct-to-consumer genetic testing market: Segmentation by service 2018 (%) Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: andMe Inc. - Vendor overview Exhibit 46: andMe Inc. - Business segments Exhibit 47: andMe Inc. - Organizational developments Exhibit 48: andMe Inc. - Key offerings Exhibit 49: Invitae Corp. - Vendor overview Exhibit 50: Invitae Corp. - Business segments Exhibit 51: Invitae Corp. - Organizational developments Exhibit 52: Invitae Corp. - Geographic focus Exhibit 53: Invitae Corp. - Key offerings Exhibit 54: Laboratory Corp. of America Holdings - Vendor overview Exhibit 55: Laboratory Corp. of America Holdings - Business segments Exhibit 56: Laboratory Corp. of America Holdings - Organizational developments Exhibit 57: Laboratory Corp. of America Holdings - Geographic focus Exhibit 58: Laboratory Corp. of America Holdings - Segment focus Exhibit 59: Laboratory Corp. of America Holdings - Key offerings Exhibit 60: Myriad Genetics Inc. - Vendor overview Exhibit 61: Myriad Genetics Inc. - Business segments Exhibit 62: Myriad Genetics Inc. - Organizational developments Exhibit 63: Myriad Genetics Inc. - Segment focus Exhibit 64: Myriad Genetics Inc. - Key offerings Exhibit 65: Quest Diagnostics Inc. - Vendor overview Exhibit 66: Quest Diagnostics Inc. - Business segments Exhibit 67: Quest Diagnostics Inc. - Organizational developments Exhibit 68: Quest Diagnostics Inc. - Geographic focus Exhibit 69: Quest Diagnostics Inc. - Segment focus Exhibit 70: Quest Diagnostics Inc. - Key offerings Exhibit 71: Validation techniques employed for market sizing Exhibit 72: Definition of market positioning of vendors

23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., and Quest Diagnostics Inc.